| Institution: | 1. Health Behaviour Research Centre, University College London, London, UK;2. Institute of Child Health, University College London, London, UK;3. Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK;1. National Vaccine Program Office, U.S. DHHS, Washington, District of Columbia;2. Emergent BioSolutions, Washington, District of Columbia;3. U.S. Food and Drug Administration, Washington, District of Columbia;4. RAND Corporation, Arlington, Virginia;5. RAND Corporation, Santa Monica, California;1. Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building Phase 2, City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK;2. Leicester City Council, Public Health Directorate, New Walk Centre, Leicester, LE1 6ZG, UK;1. Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK;2. Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK;3. Statistics Modelling and Economics Department, Health Protection Directorate, Public Health England, London NW9 5EQ, UK;4. Department of Primary Care and Public Health, School of Public Health, Imperial College, London W6 8RP, UK;1. Division of Infectious Diseases and Hospital Epidemiology, University Children''s Hospital, Zurich, Switzerland;2. Children''s Research Centre, University Children''s Hospital, Zurich, Switzerland;3. Helsana Health Insurance Company, Duebendorf, Switzerland |
